SAN DIEGO, June 26, 2024 /PRNewswire/ -- Element Biosciences, Inc., a developer of pioneering technologies to empower science, today announced the additions of two industry-leading artificial intelligence and portfolio management experts to its executive team. The appointments will build Element's leadership as it expands with innovative products and capabilities..

圣迭戈，2024年6月26日/PRNewswire/--Element Biosciences，Inc.，一家致力于增强科学能力的开创性技术的开发商，今天宣布在其执行团队中增加两名业界领先的人工智能和投资组合管理专家。随着Element凭借创新产品和能力的扩展，这些任命将建立其领导地位。。

Element is pleased to announce the appointment of Amirali Kia, PhD, as Vice President of Artificial Intelligence. Dr. Kia will apply his extensive expertise in Artificial Intelligence within the Life Sciences sector to enhance the value of Element's current and future products. His role will include optimizing the utility of the comprehensive multi-omic datasets generated by Aviti24..

Element很高兴宣布任命Amiri Kia博士为人工智能副总裁。Kia博士将在生命科学领域应用他在人工智能方面的广泛专业知识，以提高Element当前和未来产品的价值。他的职责将包括优化Aviti24生成的综合多组学数据集的效用。。

Element is also appointing Tina Tian, PhD, as Vice President of Portfolio Management. Since launching Aviti in 2022, Element has continually released new kits and chemistries, driving innovation and strong differentiation for its products. Dr. Tian will continue Element's relentless drive, taking charge of program and portfolio management..

Element还任命Tina Tian博士为投资组合管理副总裁。自2022年推出Aviti以来，Element不断推出新的试剂盒和化学试剂，推动其产品的创新和强大的差异化。田博士将继续Element的不懈努力，负责项目和投资组合管理。。

'The key to Element's success and market growth is our passionate and high-performing team who pushes the boundary of innovations. The expertise Amirali and Tina bring to Element will expedite our work to provide innovative products for the future of biology,' said Molly He, CEO, Element Biosciences.

“Element成功和市场增长的关键是我们充满激情和高绩效的团队，他们推动了创新的边界。Element Biosciences首席执行官莫莉·何（MollyHe）说，阿米拉利（Amirali）和蒂娜（Tina）为Element带来的专业知识将加速我们为生物学的未来提供创新产品的工作。

'We will continue to redefine what is possible on a sequencer and help labs around the globe shift their science into a higher gear.'.

“我们将继续重新定义测序仪上的可能性，并帮助全球各地的实验室将其科学提升到一个更高的水平。”。

About Amirali Kia, PhD, Vice President of Artificial Intelligence

Amirali brings over 12 years of expertise in applying machine learning and data science to biology and biotechnology. He has published numerous articles in the fields of machine learning and computational biology.

。他在机器学习和计算生物学领域发表了许多文章。

Before joining Element Biosciences, he served as the Vice President of AI and Data Science at Deepcell, where he helped expand the company's AI research initiatives in cell morphology. Prior to this, he was the Vice President of AI and Computational Biology at Harbinger Health, where he played a pivotal role in establishing the AI infrastructure and developing algorithms for early cancer detection in blood samples..

在加入Element Biosciences之前，他曾担任Deepcell人工智能和数据科学副总裁，在那里他帮助扩大了公司在细胞形态学方面的人工智能研究计划。在此之前，他是Harbinger Health的人工智能和计算生物学副总裁，在那里他在建立人工智能基础设施和开发血液样本中早期癌症检测算法方面发挥了关键作用。。

Amirali began his industrial career at Illumina following the completion of his PhD. As the Director of the Core-AI team, he successfully harnessed AI for various core technologies at Illumina, ranging from instrument analysis algorithms to protein engineering. His extensive industrial experience encompasses tools and instruments, large molecule discovery, and diagnostics..

Amirali在完成博士学位后，在Illumina开始了他的工业生涯。作为核心人工智能团队的负责人，他成功地将人工智能应用于Illumina的各种核心技术，从仪器分析算法到蛋白质工程。他丰富的工业经验包括工具和仪器、大分子发现和诊断。。

Amirali holds a PhD from Stanford University in High Performance Computing, with a focus on its applications in biology.

Amirali拥有斯坦福大学高性能计算博士学位，专注于其在生物学中的应用。

About Tina Tian, PhD, Vice President of Portfolio Management

关于投资组合管理副总裁Tina Tian博士

Tina brings over 25 years of management experience in the biotech industry across the areas of portfolio management, program management, R&D and CLIA laboratory management.

蒂娜在投资组合管理、项目管理、研发和CLIA实验室管理等领域拥有超过25年的生物技术行业管理经验。

Prior to joining Element, Tina was the Head of Pharma Services at Roche Diagnostics, leading a cross-functional CLIA team to provide cutting-edge clinical services to pharma customers. Before joining Roche, Tina was a Senior Director of Portfolio and Program Management at Thermo Fisher Scientific's Clinical Sequencing Division, where she played a pivotal role in building product roadmaps, establishing a PMO team as well as delivering products to customers.

在加入Element之前，Tina是罗氏诊断公司（Roche Diagnostics）的制药服务主管，领导一个跨职能的CLIA团队，为制药客户提供尖端的临床服务。在加入罗氏之前，蒂娜是Thermo Fisher Scientific临床测序部门投资组合和项目管理的高级主管，她在制定产品路线图、建立PMO团队以及向客户交付产品方面发挥了关键作用。

Tina's experience also includes senior PMO roles at Pacific Biosciences and Affymetrix..

蒂娜的经验还包括在太平洋生物科学和Affymetrix担任高级PMO。。

Tina holds a Ph.D. in Biochemistry from the Johns Hopkins Medical School and received her postdoctoral training from the National Institutes of Health.

蒂娜拥有约翰·霍普金斯医学院的生物化学博士学位，并接受了美国国立卫生研究院的博士后培训。

About Element Biosciences, Inc.

关于Element Biosciences，Inc。

Element Biosciences is a pioneering life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. We are focused on developing disruptive DNA sequencing and multi-omics technology for research markets. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries.

Element Biosciences是一家开创性的生命科学公司，将先进生物工具的使用民主化，推动有影响力的发现造福人类。我们专注于为研究市场开发破坏性DNA测序和多组学技术。通过创新生物测定系统的每个基本元素，element为客户提供了负担得起的高质量数据和改进的用户体验，这反过来将加速科学发现。

To learn more about Element, please visit www.elementbiosciences.com and follow us on LinkedIn, X (Twitter), and Facebook..

要了解更多有关Element的信息，请访问www.elementbiosciences.com，并在LinkedIn、X（Twitter）和Facebook上关注我们。。

Media Contact:

媒体联系人：

Melissa Musiker

Melissa音乐家

Element Biosciences

元素生物科学

Melissa.Musiker@elembio.com

Melissa.Musiker@elembio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/element-biosciences-fortifies-its-executive-team-with-experts-in-artificial-intelligence-and-product-development-302182417.html

查看原始内容以下载多媒体：https://www.prnewswire.com/news-releases/element-biosciences-fortifies-its-executive-team-with-experts-in-artificial-intelligence-and-product-development-302182417.html

SOURCE Element Biosciences

源元素生物科学